MYCN and ependymoma: More recently, two groups independently described another small but distinct group of spinal ependymomas characterized by MYCN amplifications and poor outcome [23, 73], which brings the total to 10 molecular groups of ependymomas that were all included in the new 5th edition of the WHO classification of CNS tumors [43].